Elevance Health Inc (ELV)
Return on equity (ROE)
| Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income (ttm) | US$ in thousands | 5,987,000 | 6,127,000 | 6,441,000 | 6,241,000 | 6,041,000 | 6,182,000 | 6,088,000 | 6,228,000 | 6,104,000 | 5,518,000 | 4,231,000 | 4,714,000 | 4,572,000 | 4,955,000 | 5,916,000 | 4,779,000 | 4,807,000 | 4,297,000 | 4,074,000 | 3,989,000 |
| Total stockholders’ equity | US$ in thousands | 39,306,000 | 38,423,000 | 38,205,000 | 37,356,000 | 36,243,000 | 36,055,000 | 35,812,000 | 35,975,000 | 36,095,000 | 35,808,000 | 34,968,000 | 33,853,000 | 33,199,000 | 33,921,000 | 34,455,000 | 31,693,000 | 31,728,000 | 31,332,000 | 30,793,000 | 29,998,000 |
| ROE | 15.23% | 15.95% | 16.86% | 16.71% | 16.67% | 17.15% | 17.00% | 17.31% | 16.91% | 15.41% | 12.10% | 13.92% | 13.77% | 14.61% | 17.17% | 15.08% | 15.15% | 13.71% | 13.23% | 13.30% |
December 31, 2023 calculation
ROE = Net income (ttm) ÷ Total stockholders’ equity
= $5,987,000K ÷ $39,306,000K
= 15.23%
The return on equity (ROE) for Elevance Health Inc has shown a slight fluctuation over the past eight quarters, ranging from 15.23% to 17.36%. Despite some variability, the ROE has generally been in the mid to high teens, indicating that the company has been effective in generating profits from the shareholders' equity. The highest ROE was recorded in Q1 2022 at 17.36%, while the lowest was seen in Q4 2023 at 15.23%.
Overall, Elevance Health Inc has maintained a healthy ROE performance, demonstrating a consistent ability to generate returns for shareholders relative to the equity invested in the company. The ROE trend suggests that the company has been efficiently utilizing its equity to generate profits, although some quarters have shown slightly lower returns. Further analysis comparing the ROE with industry peers and benchmarking against historical performance can provide additional insights into the company's financial health and operational efficiency.
Peer comparison
Dec 31, 2023